Evidence map›Paper›PMID 42334420›Full record

ArticleThe Journal of experimental medicine2026

Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.

Amirah Al Jawazneh, Imke Liebold, Stephanie Leyk, Clarissa Lanzloth, Vera Brackrock, Tamara López-López, Sebastian Graute, Irene Aranda-Pardos, Madeleine Hamley, Jonas Bahn and 12 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Amirah Al Jawazneh *I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-0327-2832
Imke Liebold *I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-9708-4735
Stephanie Leyk *I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0007-4600-3214
Clarissa LanzlothI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0006-9570-1935
Vera BrackrockI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0004-2076-9295
Tamara López-LópezDepartment of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0000-9345-907X
Sebastian GrauteDepartment of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0002-1007-6298
Irene Aranda-PardosInstitute of Immunology, University of Münster , Münster, Germany.ORCID 0000-0002-8904-1532
Madeleine HamleyI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0005-9418-8511
Jonas BahnI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0008-0704-0482
Joerg HeerenDepartment of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-5647-1034
Johann Von FeldenI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-2839-5174
Ansgar W LohseI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-8823-3129
Christoph SchrammI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-4264-1928
Dorothee SchwingeI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-0679-4476
Pablo J SáezDepartment of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-0521-9426
Noelia A-GonzalezInstitute of Immunology, University of Münster , Münster, Germany.ORCID 0000-0003-0533-5216
Samuel HuberI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-9325-8227
Thomas JacobsProtozoa Immunology, Bernhard Nocht Institute for Tropical Medicine , Hamburg, Germany.ORCID 0000-0003-3313-7866
Lorenz AdlungI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-0971-2309
Anna WorthmannDepartment of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-4731-3974
Lidia BosurgiI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-8775-4950

Funding

Deutsche Forschungsgemeinschaft 335447717Deutsche Forschungsgemeinschaft 449437943Deutsche Forschungsgemeinschaft 450149205Deutsche Forschungsgemeinschaft 530990199Deutsche Forschungsgemeinschaft BO5198/7-1State of Hamburg LFF-FV78
6 · The paper itself

Abstract

The clearance of apoptotic cells by phagocytes is crucial for restoring tissue balance after injury. In autoimmune liver diseases like primary sclerosing cholangitis, cell death is thought to result from accumulation of toxic bile acids within parenchymal cells. Whether, in this context, bile acid-loaded dying cells impact the efficiency of phagocytic macrophages in restoring tissue balance remains unknown. Here, we demonstrate that in a murine model of cholangitis, bile acids accumulate in a subpopulation of efferocytic macrophages with pro-inflammatory features. Our in vitro results indicate that, upon their engulfment, apoptotic hepatocytes laden with bile acids can serve as Trojan horses, delivering bile acids into efferocytic macrophages and thereby shaping macrophage function. This contrasts with the characteristics of macrophages that engulf apoptotic parenchymal cells lacking bile acids. Together, our findings delineate a system in which the content of the phagocytosed dying cells, specifically bile acid-laden hepatocytes, drives a pro-inflammatory program in the corresponding efferocytic macrophages, potentially contributing to chronic hepatic inflammation.

Indexed as

Bile Acids and SaltsCholangitisInflammationMacrophagesAnimalsApoptosisDisease Models, AnimalEfferocytosisHepatocytesMiceMice, Inbred C57BLPhagocytosisBile Acids and Salts

Identifiers

PMID42334420
PMCPMC13289589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.